関連する実験動画
Updated: May 9, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.7K
SF3B4とHMGB1の発現と胃がんの臨床病理学的特徴と予後に関する研究
Min-Yue Shou1, Yu-Qing Liu1, Yong-Qian Shu2
1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
World journal of gastrointestinal oncology
|August 21, 2025
まとめ
胃がんにおけるスプライシングファクター3bサブユニット4 (SF3B4) と高移動性グループボックス1 (HMGB1) の発現が増加すると,攻撃的な疾患と低生存率が相関する. SF3B4とHMGB1の組み合わせによる評価は,胃がん患者の予後精度を改善します.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 胃がんは 高い罹病率と死亡率を持つ 世界的に有数の悪性腫瘍です
- 世界中で公衆衛生に重大な問題を 抱えています
研究 の 目的:
- スプライシングファクター3bサブユニット4 (SF3B4) と高移動性グループボックス1 (HMGB1) の表現との関連を調査する.
- 胃がん患者における臨床的特徴と予後結果との相関性
主な方法:
- 胃がん患者114人と良性胃疾患患者90人を対象とした遡及コホート研究.
- SF3B4とHMGB1の発現レベルを評価するためのリアルタイム定量ポリメラーゼ連鎖反応 (RT-qPCR)
- 臨床病理学的特徴,生存データ,死亡率の予測要因に対する表現パターンの分析.
主要な成果:
- SF3B4とHMGB1は胃がん組織で著しく上位調節された.
- 高い発現レベルは 差異化,深層浸透,高度な段階などの 攻撃的な特徴と相関しています
- SF3B4とHMGB1の結合表現は,1年間の不良結果を予測する高精度 (AUC=0. 914) を示した.
結論:
- SF3B4とHMGB1の発現が増加すると,腫瘍の攻撃性や胃がんの予後が悪くなる.
- これらのバイオマーカーは患者のリスクの階層化と 結果の予測に役立ちます.
- SF3B4とHMGB1の組み合わせによる評価は,予後が悪い場合の予測精度を高めます.
関連する概念動画
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...